Nimodipine vs. Milrinone – Equal or Complementary Use? A Retrospective Analysis

Nimodipine vs. Milrinone – Equal or Complementary Use? A Retrospective Analysis

BackgroundCerebral vasospasm (CVS) continues to account for high morbidity and mortality in patients surviving the initial aneurysmal subarachnoid hemorrhage (SAH). Nimodipine is the only drug known to reduce delayed cerebral ischemia (DCI), but it is believed not to affect large vessel CVS. Milrino...

Full description

Bibliographic Details
Main Authors: Jennifer Jentzsch, Svitlana Ziganshyna, Dirk Lindner, Helena Merkel, Simone Mucha, Stefan Schob, Ulf Quäschling, Karl-Titus Hoffmann, Robert Werdehausen, Dirk Halama, Khaled Gaber, Cindy Richter
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Neurology
Subjects:
delayed cerebral ischemia
endovascular procedures
milrinone
nimodipine
subarachnoid hemorrhage
cerebral vasospasm
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.939015/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2022.939015/full

Similar Items